These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17047049)

  • 1. Coordinated functions of E-cadherin and transforming growth factor beta receptor II in vitro and in vivo.
    Andl CD; Fargnoli BB; Okawa T; Bowser M; Takaoka M; Nakagawa H; Klein-Szanto A; Hua X; Herlyn M; Rustgi AK
    Cancer Res; 2006 Oct; 66(20):9878-85. PubMed ID: 17047049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathepsin B is the driving force of esophageal cell invasion in a fibroblast-dependent manner.
    Andl CD; McCowan KM; Allison GL; Rustgi AK
    Neoplasia; 2010 Jun; 12(6):485-98. PubMed ID: 20563251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells.
    Fujimoto K; Sheng H; Shao J; Beauchamp RD
    Exp Cell Res; 2001 Jun; 266(2):239-49. PubMed ID: 11399052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of expression of TGF-beta1, TbetaRI, and TbetaRII correlates with differentiation in human oral squamous cell carcinomas.
    Mincione G; Di Marcantonio MC; Artese L; Vianale G; Piccirelli A; Piccirilli M; Perrotti V; Rubini C; Piattelli A; Muraro R
    Int J Oncol; 2008 Feb; 32(2):323-31. PubMed ID: 18202754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III.
    Deng X; Bellis S; Yan Z; Friedman E
    Cell Growth Differ; 1999 Jan; 10(1):11-8. PubMed ID: 9950213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
    Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
    Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutual regulation of TGF-β1, TβRII and ErbB receptors expression in human thyroid carcinomas.
    Mincione G; Tarantelli C; Vianale G; Di Marcantonio MC; Cotellese R; Francomano F; Di Nicola M; Costantini E; Cichella A; Muraro R
    Exp Cell Res; 2014 Sep; 327(1):24-36. PubMed ID: 24973511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transforming growth factor beta1 regulation of epithelial-mesenchymal transition in esophagus squamous cell carcinoma].
    Sun Y; Li SS; Wang XH; Wang XJ; Yan AH
    Zhonghua Bing Li Xue Za Zhi; 2008 Aug; 37(8):542-8. PubMed ID: 19094466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y; Kyprianou N
    Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of transforming growth factor-beta type II receptor reduces tumorigenicity in the human adrenocortical carcinoma SW-13 cell line.
    Yamamoto N; Imai J; Watanabe M; Hiroi N; Sugano S; Yoshino G
    Horm Metab Res; 2006 Mar; 38(3):159-66. PubMed ID: 16673206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent.
    Zúñiga JE; Groppe JC; Cui Y; Hinck CS; Contreras-Shannon V; Pakhomova ON; Yang J; Tang Y; Mendoza V; López-Casillas F; Sun L; Hinck AP
    J Mol Biol; 2005 Dec; 354(5):1052-68. PubMed ID: 16289576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid up-regulates transforming growth factor-beta (TGF-beta) type II receptor and enhances TGF-beta signaling in human prostate cancer PC-3 cells.
    Li Z; Chen Y; Cao D; Wang Y; Chen G; Zhang S; Lu J
    Endocrinology; 2006 Nov; 147(11):5259-67. PubMed ID: 16887915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pivotal role for the transmembrane domain in transforming growth factor-beta receptor activation.
    Zhu HJ; Sizeland AM
    J Biol Chem; 1999 Apr; 274(17):11773-81. PubMed ID: 10206994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF beta (transforming growth factor beta) receptor type III directs clathrin-mediated endocytosis of TGF beta receptor types I and II.
    McLean S; Di Guglielmo GM
    Biochem J; 2010 Jul; 429(1):137-45. PubMed ID: 20406198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells.
    Huo YY; Hu YC; He XR; Wang Y; Song BQ; Zhou PK; Zhu MX; Li G; Wu DC
    Cell Biol Toxicol; 2007 Mar; 23(2):113-28. PubMed ID: 17096210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling by chimeric erythropoietin-TGF-beta receptors: homodimerization of the cytoplasmic domain of the type I TGF-beta receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction.
    Luo K; Lodish HF
    EMBO J; 1996 Sep; 15(17):4485-96. PubMed ID: 8887540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate and delayed effects of E-cadherin inhibition on gene regulation and cell motility in human epidermoid carcinoma cells.
    Andersen H; Mejlvang J; Mahmood S; Gromova I; Gromov P; Lukanidin E; Kriajevska M; Mellon JK; Tulchinsky E
    Mol Cell Biol; 2005 Oct; 25(20):9138-50. PubMed ID: 16199889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outgrowth of drug-resistant carcinomas expressing markers of tumor aggression after long-term TβRI/II kinase inhibition with LY2109761.
    Connolly EC; Saunier EF; Quigley D; Luu MT; De Sapio A; Hann B; Yingling JM; Akhurst RJ
    Cancer Res; 2011 Mar; 71(6):2339-49. PubMed ID: 21282335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro.
    Meng XM; Huang XR; Xiao J; Chen HY; Zhong X; Chung AC; Lan HY
    J Pathol; 2012 Jun; 227(2):175-88. PubMed ID: 22190171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.